Lineage relationship of effector and memory T cells

Current Opinion in Immunology

Volumn 25, Issue 5, 2013, Pages 556-563

  Restifo, Nicholas P ^a   Gattinoni, Luca ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANZYME; L SELECTIN; PERFORIN; TELOMERASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

CELL FATE; CELL MATURATION; CYTOLYSIS; EFFECTOR CELL; ENZYME ACTIVITY; HUMAN; INTRAVITAL MICROSCOPY; LIPID OXIDATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; PROTEIN CLEAVAGE; REVIEW; ANIMAL; BIOLOGICAL MODEL; CELL LINEAGE; CYTOLOGY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INNATE IMMUNITY; T LYMPHOCYTE;

ANIMALS; CELL LINEAGE; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 84898019055     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.09.003     Document Type: Review

References (65)

1. 1 Sallusto, F., Geginat, J., Lanzavecchia, A., Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22 (2004), 745–763.
2. 2 Lefrancois, L., Obar, J.J., Once a killer, always a killer: from cytotoxic T cell to memory cell. Immunol Rev 235 (2010), 206–218.
3. 3 Antia, R., Ganusov, V.V., Ahmed, R., The role of models in understanding CD8+ T-cell memory. Nat Rev Immunol 5 (2005), 101–111.
4. 4 Fearon, D.T., Manders, P., Wagner, S.D., Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293 (2001), 248–250.
5. 5 Gattinoni, L., Klebanoff, C.A., Restifo, N.P., Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer 12 (2012), 671–684.
6. 6 Lanzavecchia, A., Sallusto, F., Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2 (2002), 982–987.
7. 7 Klebanoff, C.A., Gattinoni, L., Restifo, N.P., CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 211 (2006), 214–224.
8. 8 Chang, J.T., Palanivel, V.R., Kinjyo, I., Schambach, F., Intlekofer, A.M., Banerjee, A., Longworth, S.A., Vinup, K.E., Mrass, P., Oliaro, J., et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315 (2007), 1687–1691.
9. 9 Ahmed, R., Bevan, M.J., Reiner, S.L., Fearon, D.T., The precursors of memory: models and controversies. Nat Rev Immunol 9 (2009), 662–668.
10. 10 Reiner, S.L., Sallusto, F., Lanzavecchia, A., Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate. Science 317 (2007), 622–625.
11. 11 Blanpain, C., Fuchs, E., Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10 (2009), 207–217.
12. 12•• Clevers, H., The intestinal crypt, a prototype stem cell compartment. Cell 154 (2013), 274–284 Clevers and colleagues have tracked differentiation and fate of cells in the gut using R26R-Confetti ‘brainbow’ mice that utilize combinatorial expression of fluorescent proteins. They found that fluorescently labeled cells that appear first from stem cells at the base of the crypt, then form ‘clonal conveyor belt’ with cells migrating up the crypts and differentiating, eventually populating the entire surface of the intestine. The oldest cells are jettisoned via apoptosis at the villus tip.
13. 13 Kastenmuller, W., Brandes, M., Wang, Z., Herz, J., Egen, J.G., Germain, R.N., Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node. Immunity 38 (2013), 502–513.
14. 14 Jung, T.M., Gallatin, W.M., Weissman, I.L., Dailey, M.O., Down-regulation of homing receptors after T cell activation. J Immunol 141 (1988), 4110–4117.
15. 15 Peschon, J.J., Slack, J.L., Reddy, P., Stocking, K.L., Sunnarborg, S.W., Lee, D.C., Russell, W.E., Castner, B.J., Johnson, R.S., Fitzner, J.N., et al. An essential role for ectodomain shedding in mammalian development. Science 282 (1998), 1281–1284.
16. 16 Yang, S., Liu, F., Wang, Q.J., Rosenberg, S.A., Morgan, R.A., The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. PLoS ONE, 6, 2011, e22560.
17. 17 Wherry, E.J., Teichgraber, V., Becker, T.C., Masopust, D., Kaech, S.M., Antia, R., von Andrian, U.H., Ahmed, R., Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4 (2003), 225–234.
18. 18 Jacob, J., Baltimore, D., Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399 (1999), 593–597.
19. 19 Bannard, O., Kraman, M., Fearon, D.T., Secondary replicative function of CD8+ T cells that had developed an effector phenotype. Science 323 (2009), 505–509.
20. 20 Harrington, L.E., Janowski, K.M., Oliver, J.R., Zajac, A.J., Weaver, C.T., Memory CD4 T cells emerge from effector T-cell progenitors. Nature 452 (2008), 356–360.
21. 21•• Youngblood, B., Hale, J.S., Ahmed, R., T-cell memory differentiation: insights from transcriptional signatures and epigenetics. Immunology 139 (2013), 277–284 A recent and clear discussion of the alternative model to the one espoused in the present piece. Youngblood and colleagues forward the view that T cell memory is derived from effector T cells.
22. 22 D'Souza, W.N., Hedrick, S.M., Cutting edge: latecomer CD8 T cells are imprinted with a unique differentiation program. J Immunol 177 (2006), 777–781.
23. 23 Sallusto, F., Lenig, D., Forster, R., Lipp, M., Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999), 708–712.
24. 24 Papagno, L., Spina, C.A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T., Chesney, G., Waters, A., Easterbrook, P., et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol, 2, 2004, E20.
25. 25 Romero, P., Zippelius, A., Kurth, I., Pittet, M.J., Touvrey, C., Iancu, E.M., Corthesy, P., Devevre, E., Speiser, D.E., Rufer, N., Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 178 (2007), 4112–4119.
26. 26 Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C.M., Quigley, M.F., Almeida, J.R., Gostick, E., Yu, Z., Carpenito, C., et al. A human memory T cell subset with stem cell-like properties. Nat Med 17 (2011), 1290–1297.
27. 27 Gattinoni, L., Klebanoff, C.A., Palmer, D.C., Wrzesinski, C., Kerstann, K., Yu, Z., Finkelstein, S.E., Theoret, M.R., Rosenberg, S.A., Restifo, N.P., Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest 115 (2005), 1616–1626.
28. 28 Wirth, T.C., Xue, H.H., Rai, D., Sabel, J.T., Bair, T., Harty, J.T., Badovinac, V.P., Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation. Immunity 33 (2010), 128–140.
29. 29 Best, J.A., Blair, D.A., Knell, J., Yang, E., Mayya, V., Doedens, A., Dustin, M.L., Goldrath, A.W., Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation. Nat Immunol 14 (2013), 404–412.
30. 30•• Zhu, J., Adli, M., Zou, J.Y., Verstappen, G., Coyne, M., Zhang, X., Durham, T., Miri, M., Deshpande, V., De Jager, P.L., et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152 (2013), 642–654 This paper provides evidence that cells experience progressive changes in chromatin with differentiation. The authors perform detailed epigenetic studies on a large and diverse collection of human tissues and stem cells to find that developmental specification is accompanied by progressive chromatin restriction.
31. 31 Willinger, T., Freeman, T., Hasegawa, H., McMichael, A.J., Callan, M.F., Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J Immunol 175 (2005), 5895–5903.
32. 32 Holmes, S., He, M., Xu, T., Lee, P.P., Memory T cells have gene expression patterns intermediate between naive and effector. Proc Natl Acad Sci U S A 102 (2005), 5519–5523.
33. 33 Joshi, N.S., Cui, W., Chandele, A., Lee, H.K., Urso, D.R., Hagman, J., Gapin, L., Kaech, S.M., Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27 (2007), 281–295.
34. 34 Kalia, V., Sarkar, S., Subramaniam, S., Haining, W.N., Smith, K.A., Ahmed, R., Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32 (2010), 91–103.
35. 35 Hand, T.W., Cui, W., Jung, Y.W., Sefik, E., Joshi, N.S., Chandele, A., Liu, Y., Kaech, S.M., Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A 107 (2010), 16601–16606.
36. 36 Rutishauser, R.L., Martins, G.A., Kalachikov, S., Chandele, A., Parish, I.A., Meffre, E., Jacob, J., Calame, K., Kaech, S.M., Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31 (2009), 296–308.
37. 37 Masson, F., Minnich, M., Olshansky, M., Bilic, I., Mount, A.M., Kallies, A., Speed, T.P., Busslinger, M., Nutt, S.L., Belz, G.T., Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation. J Immunol 190 (2013), 4585–4594.
38. 38 Knell, J., Best, J.A., Lind, N.A., Yang, E., D'Cruz, L.M., Goldrath, A.W., Id2 influences differentiation of killer cell lectin-like receptor G1(hi) short-lived CD8+ effector T cells. J Immunol 190 (2013), 1501–1509.
39. 39 Kim, E.H., Sullivan, J.A., Plisch, E.H., Tejera, M.M., Jatzek, A., Choi, K.Y., Suresh, M., Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J Immunol 188 (2012), 4305–4314.
40. 40 Jeannet, G., Boudousquie, C., Gardiol, N., Kang, J., Huelsken, J., Held, W., Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc Natl Acad Sci U S A 107 (2010), 9777–9782.
41. 41 Zhou, X., Yu, S., Zhao, D.M., Harty, J.T., Badovinac, V.P., Xue, H.H., Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity 33 (2010), 229–240.
42. 42 Gattinoni, L., Zhong, X.S., Palmer, D.C., Ji, Y., Hinrichs, C.S., Yu, Z., Wrzesinski, C., Boni, A., Cassard, L., Garvin, L.M., et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med 15 (2009), 808–813.
43. 43 Kim, M.V., Ouyang, W., Liao, W., Zhang, M.Q., Li, M.O., The transcription factor foxo1 controls central-memory CD8(+) T cell responses to infection. Immunity 39 (2013), 286–297.
44. 44 Michelini, R.H., Doedens, A.L., Goldrath, A.W., Hedrick, S.M., Differentiation of CD8 memory T cells depends on Foxo1. J Exp Med 210 (2013), 1189–1200.
45. 45 Cui, W., Liu, Y., Weinstein, J.S., Craft, J., Kaech, S.M., An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 35 (2011), 792–805.
46. 46 Ji, Y., Pos, Z., Rao, M., Klebanoff, C.A., Yu, Z., Sukumar, M., Reger, R.N., Palmer, D.C., Borman, Z.A., Muranski, P., et al. Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells. Nat Immunol 12 (2011), 1230–1237.
47. 47 Yang, C.Y., Best, J.A., Knell, J., Yang, E., Sheridan, A.D., Jesionek, A.K., Li, H.S., Rivera, R.R., Lind, K.C., D'Cruz, L.M., et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat Immunol 12 (2011), 1221–1229.
48. 48•• Buchholz, V.R., Flossdorf, M., Hensel, I., Kretschmer, L., Weissbrich, B., Graf, P., Verschoor, A., Schiemann, M., Hofer, T., Busch, D.H., Disparate individual fates compose robust CD8+ T cell immunity. Science 340 (2013), 630–635 Together with Refs. [49,50], this paper comprises an analysis of the fate and differentiation of individual T cells during infection. These papers contain data that are consistent with a model of progressive T cell differentiation, where memory cells are progenitors of effector cells, and not vice versa. Buchholz et al propose a model of T cell differentiation that is consistent with one published by Klebanoff et al. in 2006 (Ref. [7]).
49. 49 Gerlach, C., Rohr, J.C., Perie, L., van Rooij, N., van Heijst, J.W., Velds, A., Urbanus, J., Naik, S.H., Jacobs, H., Beltman, J.B., et al. Heterogeneous differentiation patterns of individual CD8+ T cells. Science 340 (2013), 635–639.
50. 50 Plumlee, C.R., Sheridan, B.S., Cicek, B.B., Lefrancois, L., Environmental cues dictate the fate of individual CD8 T cells responding to infection. Immunity, 2013.
51. 51 Restifo, N.P., Dudley, M.E., Rosenberg, S.A., Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12 (2012), 269–281.
52. + T cells into memory or effector cells.
53. 53 Chang, C.H., Curtis, J.D., Maggi, L.B. Jr., Faubert, B., Villarino, A.V., O'Sullivan, D., Huang, S.C., van der Windt, G.J., Blagih, J., Qiu, J., et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153 (2013), 1239–1240.
54. 54 Pearce, E.L., Walsh, M.C., Cejas, P.J., Harms, G.M., Shen, H., Wang, L.S., Jones, R.G., Choi, Y., Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460 (2009), 103–107.
55. 55 Chang, H.H., Hemberg, M., Barahona, M., Ingber, D.E., Huang, S, Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 453 (2008), 544–547.
56. 56 Wang, R., Green, D.R., Metabolic checkpoints in activated T cells. Nat Immunol 13 (2012), 907–915.
57. 57 Pearce, E.L., Pearce, E.J., Metabolic pathways in immune cell activation and quiescence. Immunity 38 (2013), 633–643.
58. 58 Zhou, J., Shen, X., Huang, J., Hodes, R.J., Rosenberg, S.A., Robbins, P.F., Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol 175 (2005), 7046–7050.
59. 59 Rosenberg, S.A., Yang, J.C., Sherry, R.M., Kammula, U.S., Hughes, M.S., Phan, G.Q., Citrin, D.E., Restifo, N.P., Robbins, P.F., Wunderlich, J.R., et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 17 (2011), 4550–4560.
60. 60 Huang, J., Kerstann, K.W., Ahmadzadeh, M., Li, Y.F., El-Gamil, M., Rosenberg, S.A., Robbins, P.F., Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. J Immunol 176 (2006), 7726–7730.
61. 61 Robbins, P.F., Dudley, M.E., Wunderlich, J., El-Gamil, M., Li, Y.F., Zhou, J., Huang, J., Powell, D.J. Jr., Rosenberg, S.A., Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J Immunol 173 (2004), 7125–7130.
62. 62 Klebanoff, C.A., Gattinoni, L., Torabi-Parizi, P., Kerstann, K., Cardones, A.R., Finkelstein, S.E., Palmer, D.C., Antony, P.A., Hwang, S.T., Rosenberg, S.A., et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A 102 (2005), 9571–9580.
63. 63 Hinrichs, C.S., Spolski, R., Paulos, C.M., Gattinoni, L., Kerstann, K.W., Palmer, D.C., Klebanoff, C.A., Rosenberg, S.A., Leonard, W.J., Restifo, N.P., IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 111 (2008), 5326–5330.
64. 64 Hinrichs, C.S., Borman, Z.A., Cassard, L., Gattinoni, L., Spolski, R., Yu, Z., Sanchez-Perez, L., Muranski, P., Kern, S.J., Logun, C., et al. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci U S A 106 (2009), 17469–17470.
65. 65 Klebanoff, C.A., Gattinoni, L., Palmer, D.C., Muranski, P., Ji, Y., Hinrichs, C.S., Borman, Z.A., Kerkar, S.P., Scott, C.D., Finkelstein, S.E., et al. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice. Clin Cancer Res 17 (2011), 5343–5350.